Myxoinflammatory fibroblastic sarcoma (MIFS) is a recently defined rare tumor. It is mainly found in the upper and lower extremities of adults. Due to its high local recurrence rate and low metastatic rate, it is classified as a low grade-malignancy. Accurate diagnosis and early, wide excision are important for prognosis. Herein, we report a case of MIFS in a 35-year-old male patient that presented in an unusual location, the left chest wall. To our knowledge, this is the first reported case of MIFS in Korea and the second case to be reported within the global scientific literature involving the chest wall.
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CASE REPORT
A 35-year-old man visited our hospital presenting with a palpable mass on his left lateral chest wall, which was movable, rubbery, and non-tender. A gun biopsy assisted by ultrasonography was performed, but failed to confirm a specific diagnosis; therefore, we performed a local excision. The mass was 3×2×1 cm, non-adhesive, round, and pink; the cut sections evidenced well-demarcated, gray-white gelatinous masses. A microscopic examination revealed a tumor in the subcutaneous tissues without invasion to the adjacent structures ( Fig. 1) . The specimen exhibited a mixture of myxoid, hyaline, and inflammatory zones (Fig. 2 ). Scattered and enlarged tumor cells, each with a large eosinophilic nucleus resembling a virocyte, were observed, consistent with a diagnosis of myxoinflammatory fibroblastic sarcoma (MIFS) (Fig. 3A, B ).
An immunohistochemical study revealed that the tumor cells had a strong positivity for vimentin and focal positivity for CD34 and CD68, confirming the diagnosis of MIFS.
A microscopic histological analysis of the specimen revealed that the mass was abutting to the resection margin in a series of multifocal areas. Thus, an additional wide excision was advised for an adequate tumor-free margin. On combined positron emission tomography and computed tomography, fluoro-2-deoxy-D-glucose uptake was increased at the left chest wall, probably due to a previous procedure; multiple nodules were also observed in the right lung, suggesting possible lung metastasis.
After administering general anesthesia and single-lung ventilation, a wedge resection of the right upper lung, including the nodules, was performed under video-assisted thoracoscopic surgery conditions. The frozen sectional diagnosis of the lung nodules confirmed a benign pneumocyte hyperplasia.
Subsequently, a wide left chest wall excision was performed, including partial resections of the 5th, 6th, and 7th ribs. The tumor free margin of the subcutaneous and muscle layers was In 80% of cases, the lesion involves the subcutaneous tissues of the hands or feet [2] , but it can be also be found on the elbows, thighs, or shoulders; thus the term "acral" was or of a myxoid origin [2, 5] . Because of the difficulty of an accurate diagnosis from the lesion's clinical presentation or radiological characteristics, the diagnosis is often delayed and a surgical excision is more likely to be suboptimal.
The local recurrence rate of the tumor is high (range, 22%
to 67%) when a local excision alone has been performed, usually being reported between 3 months and 5 years postoperatively [4] . The distant metastasis rate is low (6.5%);
however, cases have reported metastasis to the lung, neck, and skull [6, 7] . One tumor-related death has been reported [6] .
Although the treatment process has not been well-defined, a complete excision with clear margins is recommended.
Postoperative radiotherapy may be a good additional therapy for patients who have a large tumor or a positive resection margin [2, 8] . Some papers also report chemotherapy as an option [4] .
There has only been one other reported case of MIFS involving the chest wall. Premalata et al. [5] reported upon a MIFS of the upper back, over the scapula. They performed a wide excision of the tumor, without rib resection, and reported no recurrence within 10 months after surgery. We performed a wider local excision with a tumor free margin of 4 cm, including an adjacent rib resection and the reconstruction of the chest wall, in accordance with the guidelines for a malignant tumor of the chest wall.
In summary, MIFS is a very rare tumor that predominantly affects the distal extremities. It has not been previously described in the Korean literature. We report the first case of MIFS in Korea, and the second such tumor to be described in the chest wall. The patient underwent a wide local excision and a chest wall reconstruction.
